Surveillance of Healthcare-associated Infections in NI

Slides:



Advertisements
Similar presentations
Developments from the National Quality Board: A New Objective for MRSA Derek Butler Registered Charity No
Advertisements

Infection Prevention and Control Jo Lickiss Nurse Consultant Infection Prevention and Control.
Space-Time Relations of Clostridium difficile cases within a health economy: A Social Network Analysis Presented by Mark Reacher network analysis by Iain.
MRSA Methicillin Resistant Staphylococcus Aureus
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
MRSA PREPARED BY SARA ABUHIMED. Methicillin-resistant Staphylococcus Aureus (MRSA) is a type of bacteria that is resistant to certain antibiotics. These.
(methicillin-resistant Staphylococcus aureus)
Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre & Beaumont Hospital, Dublin, Ireland HPSC, SARI and National HCAI.
. Nosocomial Antibiotic Resistant Organisms Copyright © Texas Education Agency, All rights reserved.
Infection Prevention & Control (IPAC) at RCHT Dr Tristan Clark Infectious Diseases physicin and joint DIPC.
CSI 101 Skills Lab 2 Standard Precautions Personal Protective Equipment (PPE) Daryl P. Lofaso, M.Ed, RRT.
Briefing on 4th Meeting of Antimicrobial Resistance National Focal Points Ljubljana (Slovenia), 13 March 2008 Dominique L. Monnet Senior Expert, Antimicrobial.
MRSA 2006 Community Infection Control Nurses
SPM 100 Clinical Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT.
© Aurora Health Care, Inc. Carbapenem Resistant Enterobacteriaceae The Alphabet Soup of Infection Prevention Aurora Health Care System Infection Prevention.
Moving forward together infection prevention and control and AMR Rose Gallagher Nurse Advisor Infection Prevention and Control Royal College of Nursing.
Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated.
ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.
SPM 100 Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT Clinical Skills Lab Coordinator.
Epidemiology of Hospital Acquired Infections By Alena Bosconi, Candice Smith, Dusica Goralewski SUNY Delhi Biol , Infection and Disease Dr. Marsha.
Using AMR surveillance for developing policy AMR meeting Washington 13 April 2016.
Epidemiological measureas. How do we determine disease frequency for a population?
Nosocomial Antibiotic Resistant Organisms
MRSA Regina Livshits RN MSN NYU Langone Medical Center
Antibiotics: handle with care!
Point Prevalence Survey in a Long Term Care Facility, 2016
PRESURE ULCER Pressure ulcers cause pain, decrease quality of life, and lead to significant morbidity and prolonged hospital stays, in part due to complicating.
Created by: Alexandrea, Erika, Menna and Tia
MRSA Methicillin Resistant Staphylococcus Aureus
Member Bumps and MRSA: Not a Good Combo
Welcome Dr. Eleri Davies, Faculty Lead HCAI.
NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Professor Alan Johnson Department of HCAI & AMR
Ashry Gad Mohamed Prof. of Epidemiology
Antibiotics: handle with care!
Bacteraemia in Buckinghamshire Healthcare NHS Trust
ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.
HOSPITAL INFECTIONS Norazli Ghadin.
Frailty Programme Fran Rose-Smith June 2018.
CSI 101 Skills Lab 3 Universal Precautions and
Hospital acquired infections/ Nosocomial infections
APIC Greater new York Chapter 13
HAI August 30, 2017.
HAI January 24, 2018.
Infection Control in ANesthesia
HAI Sept. 25, 2017.
CNISP & CIHI MRSA infection rate comparison Preliminary results
Report Back Track 6: Population Health Track
Neonatal sepsis in Kilifi
Gram Negative Bacteria
MRSA=Methicillin resistant Staphylococcus aureus
A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals  M. Nagao  Clinical Microbiology and.
Removal of sinks from ICU Patient rooms
“Bug of the month “ Pseudomonas aeruginosa (Gram negative bacilli)
Lacie Shea, Gracyn Fuller
Acinetobacter Baumannii
Ambitions and Trajectories
Strain relatedness of meticillin-resistant Staphylococcus aureus isolates recovered from patients with repeated bacteraemia  C-H. Liao, C-C. Lai, S-Y.
Epidemiological Terms
National Center for Emerging and Zoonotic Infectious Diseases
Reducing Gram-negative bacteraemias: A Scottish Perspective A-Lan Banks Health Protection Scotland March 2019.
Tony Crockford & Muhammad Sartaj.
Point prevalence survey (PPS) of healthcare associated infections (HAI) & antimicrobial use (AMU) in acute care Mark McConaghy, Dr Muhammad Sartaj,
Current Threats to Public Health
EARS-Net results 2011 Ole Heuer
Antibiotics: handle with care!
Gram Negative Bacteraemia – Challenges & Opportunities in NI
Antimicrobial Stewardship – Northern Ireland Experience
Presentation transcript:

Surveillance of Healthcare-associated Infections in NI Rachel Spiers Senior Epidemiological Scientist, HCAI Team rachel.spiers@hscni.net Germs by Vectors Market from the Noun Project

HCAI Surveillance Detection Analysis Timely action Building Information Public communication The Public Health Agency’s Health Protection Surveillance Team is mandated by the Department of Health to undertake surveillance of healthcare-associated infections (HCAI). The surveillance of HCAIs has a number of goals: 1. Detection of changes in the temporal, geographic and age distribution of new and known diseases, or changes in the pattern of diseases and their risk factors 2. Analysis which can determine the exposure, prevalence, burden, morbidity, mortality, carriage and long term trends of HCAI 3. Timely action to protect the public’s health 4. Building information on the temporal, geographic and population distribution and epidemiology of new, poorly-understood and well-understood diseases for information public health decision-making, health service planning, risk management, research and infection control programmes 5. Informing the public about the risk of communicable diseases 6. Contributing to European and International efforts to protect health Surveillance by Rose Alice Design from the Noun Project

Organisms Under Surveillance 18/19 S. Aureus bacteramias C. Difficile (age 2 +) Gram-negative bacteraemias P. Aeruginosa Klebsiella spp. E. coli Pseudomonas neonatal settings augmented care Mandatory surveillance for Meticillin-sensitive and Meticillin-resistant Staphylococcus aureus (MSSA and MRSA, respectively) bloodstream infection was introduced in April 2001. Staphylococcus aureus (S. aureus) is a round shaped bacterium which commonly colonises the nose, respiratory tract, gut mucosa and the skin usually without causing any problems. It can also cause disease, particularly if there is an opportunity for the bacteria to enter the body, for example through broken skin or a medical procedure (including operations and intravenous lines). If these bacteria enter the body, illnesses which range from mild to life threatening may develop. These can include skin and wound infections, abscesses, endocarditis, pneumonia and bacteraemia (blood stream infection). Mandatory surveillance of Clostridium difficile infection (CDI) in hospitals Northern Ireland was introduced in January 2005, with enhanced surveillance of community-onset CDI following in 2011. C. difficile is a bacterium that can infect the bowel and cause diarrhoea. The infection most commonly affects people who have recently been treated with antibiotics, and can spread by spores found within faeces. Infections can occur where many people take antibiotics and are in close contact with each other, such as hospitals and care homes. The enhanced surveillance programme of Pseudomonas colonisations in neonatal units commenced in January 2013 following a recommendation [3] arising after outbreaks in neonatal units.Pseudomonas is an important cause of healthcare-associated infection, particularly in patients who are very ill or immunocompromised. Individuals may be colonised on the skin surface, nose and throat, usually without problems. Infections of the bloodstream are, however, particularly serious. And also gram-negative bloodstream infections – new for 17/18 to include P. aeruginosa, Klebsiella and E.coli. blood by Aziz Muttaqin from the Noun Project. Stomach by mungang kim from the Noun Project, Germ by Fer Guerrero from the Noun Project, medical sign by Artieady Budiman from the Noun Project, Nurse Holding Newborn by Gan Khoon Lay from the Noun Project

Data Sources Some of you will be most familiar with HI-Surv – data entered by infection control Notifications form duty room – community CDI Validated by corsurv Held in database Reporting – paper/Hi-Surv/PF Dashboard Microscope by Jacopo Bonacci from the Noun Project, Phone by Juliette Design from the Noun Project, Phone by Juliette Design from the Noun Project, dashboard by Xinh Studio from the Noun, dietitian by Made from the Noun Project, Computer by Sergey from the Noun Project, database by Putra Theoo from the Noun Project

MRSA For 2017, the MRSA rate decreased by 25% to 0.03 per 1000 bed days in Northern Ireland (45 cases) compared to 2016 - the lowest rate observed in Northern Ireland since surveillance began. The highest rates were identified in males over the age of 75 (rate 19.80, 24% of all MRSA), followed by females over the age of 75 (rate 15.16, 27% of all MRSA). The highest rates per 100,000 population were observed in the Belfast Trust (6.19), followed by Northern Trust (2.53). blood by Aziz Muttaqin from the Noun Project

MRSA Targets (NI) Annual Target 34 (2.8 cases per month) To date we have had… 47 (against target to end Jan 28)

C. Difficile The annual regional rate per 1000 occupied bed days for inpatient CDI between 2010 and 2017 is presented below. Since reporting began there have been significant reductions in CDI rates for inpatients. For 2017, the inpatient CDI rate (for those over the age of 2) increased by 3% to 0.21 per 1000 bed days in Northern Ireland compared to 2016. The highest rates were identified in males over the age of 75 (rate 129.59, 22% of all CDIs), followed by females over the age of 75 (Rate 128.86, 32% of all CDIs). The highest rates per 100,0000 population were observed in the Belfast Trust (26.43), followed by Western Trust (23.22).

C. Difficile Targets (NI) Annual Target 320 (27 cases per month) To date we have had… 301 (against target to end Jan 267)

C. Difficile in the Community When directly comparing the 2011/12 and the 2017/18 years, there has been an observed 23.5% reduction in the number of CDI inpatient cases. The number of cases of community CDI (117) has been at its lowest since reporting began. Poster – check it out

Pseudomonas in Neonatal Units Multiple isolates of a single strain were not detected between patients. No environmental/water links were reported to the HCAI Team. **Note - illustrates count of isolates only. Patients may have had one colonisation reported. Nurse Holding Newborn by Gan Khoon Lay from the Noun Project medical sign by Artieady Budiman from the Noun Project

New for 2019/20 Full integration of Community CDI to Hi-Surv, including a Community Dashbaord Hi-Surv Stakeholder Events Contribute to ECDC European-wide CDI surveillance Risk factor analysis for GNB Community by IOHK Design Department from the Noun Project, Europe by anbileru adaleru from the Noun Project, Stomach by mungang kim from the Noun Project, Germ by Fer Guerrero from the Noun Project, blood by Aziz Muttaqin from the Noun Project

Further Information New public facing dashboard – available soon

Questions? Rachel.spiers@hscni.net